Co-Founder and Board Director

Chief Financial Officer

Apogee Therapeutics CMO Carl Dambkowski Sells Shares

Apogee Therapeutics to Participate at the Stifel 2025 Virtual Immunology and Inflammation Forum

Apogee Therapeutics expects cash to fund operations into Q1 of 2028

Apogee Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary

Associate Director, QC Data and Materials Management

Apogee Therapeutics is a biotechnology company focused on developing differentiated biologics for various inflammatory and immunology indications. The Associate Director, QC Data and Materials Management will oversee QC critical reagents and reference standard management, along with QC data management and administration of the QC LIMS system.

VP, Head of People

Vice President, Quality Control

Senior Vice President, Quality Assurance

Director, GMP QA

Sign up with Google

Sign in with Google